SRPT icon

Sarepta Therapeutics
SRPT

Overview Fund Activity

340 hedge funds and large institutions have $5.52B invested in Sarepta Therapeutics in 2019 Q3 according to their latest regulatory filings, with 73 funds opening new positions, 128 increasing their positions, 101 reducing their positions, and 95 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
340
Holders Change
-25
Holders Change %
-6.85%
% of All Funds
7.47%
Holding in Top 10
8
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-38.46%
% of All Funds
0.18%
New
73
Increased
128
Reduced
101
Closed
95
Calls
$232M
Puts
$241M
Net Calls
-$9.72M
Net Calls Change
-$120M

Top Buyers

1
State Street
State Street
Massachusetts
+$62.7M
2
CCM
Cadian Capital Management
New York
+$53M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$52.5M
4
Artisan Partners
Artisan Partners
Wisconsin
+$48.3M
5
BlackRock
BlackRock
New York
+$43.9M

Top Sellers

1
TCM
TimesSquare Capital Management
New York
-$191M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$85.6M
3
PHS
PFM Health Sciences
California
-$83.1M
4
FCM
Farallon Capital Management
California
-$76M
5
RG
Redmile Group
California
-$62.6M
Name Holding Trade Value Shares
Change 		Shares
Change %
DWM
426
Doyle Wealth Management
Florida
– -$8K -50 Closed
PCP
427
Proficio Capital Partners
Massachusetts
– -$7K -49 Closed
GEA
428
Glen Eagle Advisors
New Jersey
– -$6.08K -40 Closed
TAIM
429
TD Ameritrade Investment Management
Nebraska
– -$2K -13 Closed
IFAM
430
Institutional & Family Asset Management
Colorado
– -$2K -13 Closed
GAM
431
Griffin Asset Management
New York
– -$1K -4 Closed
14 15 16 17
18